Roivant Sciences Ltd. — Director's Dealing 2023

May 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2023-05-04

Reporting Person: Venker Eric (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-04	Common Shares	M	88838	$3.85	Acquired	764606	Direct
2023-05-04	Common Shares	S	88838	$8.3	Disposed	675768	Direct
2023-05-08	Common Shares	M	61206	$3.85	Acquired	736974	Direct
2023-05-08	Common Shares	S	61206	$8.93	Disposed	675768	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-04	Stock Option (Right to Buy)	$3.85	M	88838	Disposed	2032-04-19	Common Shares (88838)	Direct
2023-05-08	Stock Option (Right to Buy)	$3.85	M	61206	Disposed	2032-04-19	Common Shares (61206)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023.

F2: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).